A new study done by researchers at Wake Forest Baptist Medical Center provides evidence that a CVD polypill may be a viable option for developing countries, where CVD is strongly emerging and the demand for cost-effective, low maintenance treatment is high.
Medical Center finds that depression and other psychological disorders may be more prevalent in adolescent acne patients.
Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center and colleagues reported today on a new advance in tissue engineering. The team is the first in the world to use patients’ own cells to build tailor-made urinary tubes and successfully replace damaged tissue.
Dermatologist at Wake Forest University Baptist Medical Center who has done tanning research is available to comment about the American Academy of Pediatrics support of legislation to ban tanning by minors.
A feasibility study to test the use of a scalp cooling device that breast cancer patients will wear while undergoing chemotherapy treatment will be conducted at Wake Forest University Baptist Medical Center.
Researchers at Wake Forest University Baptist Medical Center (WFUBMC) have discovered what may become a new weapon in the fight against breast cancer.
Orthopaedic researchers at Wake Forest University Baptist Medical Center (WFUBMC) have been awarded a $2.24 million four-year grant from the U. S. Department of Defense (DOD) to study the use of keratin gel in the regeneration of damaged peripheral nerves, those in the hands, arms and feet.
A groundbreaking, first in humans vaccine will be tested in an early phase clinical trial that will soon begin at Wake Forest University Baptist Medical Center. Eighteen patients will be the first in the world to receive it.
Tying in with this year’s conference theme, "Where Discovery Meets Innovation,” two new pre-conference workshops will debut at this year’s TERMIS-North America 2010 Conference and Expo (December 5-8, 2010) in Orlando, Fla.
Cell phone allergic contact dermatitis is becoming more of an issue. Steve Feldman, M.D., a professor of Dermatology at Wake Forest Baptist, published a paper in Dermatology Online Journal in June detailing his findings on this topic.
Wake Forest University Baptist Medical Center emergency physician Mary Claire O’Brien, M.D., who conducted groundbreaking research into the dangers of manufactured alcoholic energy drinks, is hopeful the FDA will take action.
Arsenic, a toxic compound with a reputation as a good tool for committing homicide, has a significant positive effect on the survival of patients with acute promyelocytic leukemia (APL), when administered after standard initial treatment, according to a new, multi-center study led by a researcher at Wake Forest University Baptist Medical Center.
Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center have reached an early, but important, milestone in the quest to grow replacement livers in the lab. They are the first to use human liver cells to successfully engineer miniature livers that function – at least in a laboratory setting – like human livers. The next step is to see if the livers will continue to function after transplantation in an animal model.
Keynote speakers have been announced for the TERMIS-North America Conference and Expo, set for Dec. 5-8 at the Hilton in the Walt Disney World® Resort in Orlando, Fla. This year’s conference theme is "Where Discovery Meets Innovation.”
The Center for Botanical Lipids and Inflammatory Disease Prevention at Wake Forest University Baptist Medical Center has received a $7.5 million, five-year competitive award announced by the National Institutes of Health (NIH).
At least a quarter of patients who have suffered a stroke stop taking one or more of their prescribed stroke prevention medications within the first three months after being hospitalized – when the chance of having another stroke is highest – according to a new study by researchers at Wake Forest University Baptist Medical Center and colleagues.
A new study by researchers at Wake Forest University Baptist Medical Center (WFUBMC) may soon help to spare some women with breast cancer from having to undergo invasive and toxic treatments for their disease.
A major breakthrough in how to target and destroy the most malignant and aggressive brain cancer cells has been made by researchers at Wake Forest University Baptist Medical Center.
Millions of Americans in the early stages of chronic kidney disease (CKD) are at an increased risk of having atrial fibrillation (AF) – a major risk factor for stroke – according to new research by investigators at Wake Forest University Baptist Medical Center.
Ross Ungerleider, M.D., M.B.A., a national leader and pioneer in pediatric cardiothoracic surgery programs, has joined Brenner Children’s Hospital at Wake Forest University Baptist Medical Center as chief of the pediatric cardiovascular surgery team and director of the pediatric heart program.
In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.
A group of researchers from Wake Forest University Baptist Medical Center (WFUBMC) is developing a way to treat cancer by using lasers to light up tiny nanoparticles and destroy tumors with the ensuing heat.
A good night’s sleep is crucial to daily function, but more than 40 million Americans live with an undiagnosed or untreated sleep disorder in the United States. At Wake Forest University Baptist Medical Center, the sleep-challenged can find help at the Sleep Center, now conveniently located at the Hawthorne Inn to provide patients with the highest quality of care in a comfortable and relaxing environment.
Kidney disease is a growing public health problem, with approximately half a million individuals in the United States requiring dialysis treatments to replace the function of their failed kidneys. The problem is particularly acute among African-Americans, whose rates of kidney disease are four times higher than those of European Americans.
In an effort to extend the length of a disability-free life for older adults, researchers from Wake Forest University Baptist Medical Center are partnering with colleagues from across the US and Australia in the largest international trial ever sponsored by the US National Institute on Aging (NIA).
In the first ever published estimate of the percentage and number of cancer survivors who live with their minor children, a team led by a Wake Forest University Baptist Medical Center researcher found that millions of cancer survivors are parenting young children, highlighting a group of survivors with very special needs.
An international conference attended by more than 70 of the world’s leading experts and investigators in the field of Ephs and ephrins was held in Winston-Salem, NC, this week and hosted by Waldemar Debinski, M.D., Ph.D., director of the Brain Tumor Center of Excellence at Wake Forest University Baptist Medical Center.
A new study done by researchers at Wake Forest University Baptist Medical Center indicates that chest pain may no longer have to mean a hospital stay – there is another option for diagnosing heart-related chest pain that costs less and, in some cases, allows the patient to return home the same day.
A new study led by a Wake Forest University Baptist Medical Center researcher shows that millions of cancer survivors are forgoing needed medical care because of concerns about cost.
Don Moss earns distinction of most volunteer hours worked in the world - 47, 000 and counting.
Backed by a $2.5 million grant from the National Institutes of Health, Pradeep Garg, Ph.D., and research colleagues at Wake Forest Baptist and Duke University Medical Center are conducting research to improve the effectiveness of nicotine vaccination for cigarette smokers.
Wake Forest University Baptist Medical Center has earned The Joint Commission’s Gold Seal of Approval™ in five areas.
Raymond S. Garrison, D.D.S., M.S., professor and chair of the Department of Dentistry at Wake Forest University School of Medicine and President of University Dental Associates, received the American Dental Partners (ADP) 2009 Doctor Leader of the Year Award on March 19 at ADP’s Annual Best Practices Meeting in Boston.
Kimberley J. Hansen, M.D., professor of surgery and interim chair of the Department of Vascular and Endovascular Surgery at Wake Forest University Baptist Medical Center, has been inducted into the Halsted Society.
Leaders in the field of regenerative medicine spoke about the potential to transform medicine through new treatments that focus not just on treating disease – but on cures – at the first annual Translational Regenerative Medicine Forum.
A new study by researchers at Wake Forest University Baptist Medical Center is the first to refute the widely held belief that intentional weight loss in older adults leads to increased risk of death.
A one-day intensive course on stem cells and regenerative medicine will enable journalists to learn the latest from world experts – from the scientist who developed and implanted the world’s first engineered organ to venture funding executive who has been financing health care companies for 30 years. Full scholarships are available.
The Regenerative Medicine Foundation is pleased to announce a special “Young Minds” graduate student registration rate for its annual Translational Regenerative Medicine Forum, set for April 6-8 in Winston-Salem.
Wake Forest University Baptist Medical Center, together with Wake Forest University, will play a key role in a new study that seeks to determine whether a program of structured physical activity can prevent or delay major mobility disabilities in older adults.
Vitamin D is quickly becoming the "go-to" remedy for treating a wide range of illnesses, from osteoporosis to atherosclerosis. However, new evidence from a Wake Forest University School of Medicine study suggests that supplementing vitamin D in those with low levels may have different effects based on patient race and, in black individuals, the supplement could actually do harm.
In this one-day academy for journalists, world experts will discuss the science and business of regenerative medicine, including what treatments are on the horizon and what challenges must be overcome to make new treatments widely available.
What regenerative medicine therapies are being applied to patients today? What hurdles stand between stem cell therapies and real treatments in the clinic? Keynote speakers at the upcoming inaugural Translational Regenerative Medicine Forum will discuss these topics as well as provide an update on various national and regional stem cell initiatives. The forum, set for April 6-8 in Winston-Salem, is an annual event to focus on fulfilling the promise of regenerative medicine, including best practices and business models.
Not getting enough sleep does more damage than just leaving you with puffy eyes. It can cause fat to accumulate around your organs – more dangerous, researchers say, than those pesky love handles and jiggly thighs.
A spray-on skin product and an injectable cell therapy for heart attack patients are among 17 regenerative medicine technologies that will be showcased during the Translational Regenerative Medicine Forum, set for April 6-8 in Winston-Salem. The event will include more than 60 speakers.
A comparison of two types of minimally invasive surgery to repair kidney blockages that prevent urine from draining normally to the bladder found that robot-assisted surgery was faster and resulted in less blood loss and shorter hospital stays.
Thomas D. DuBose Jr., M.D., the Tinsley R. Harrison Professor and Chair of Internal Medicine at Wake Forest University Baptist Medical Center, has been elected to the Board of Regents of the American College of Physicians (ACP).
William C. Little, M.D., chief of cardiology and McMichael Professor of Internal Medicine at Wake Forest University Baptist Medical Center, has been appointed chair-elect of the cardiovascular disease subspecialty board of the American Board of Internal Medicine (ABIM)
The Emergency Department at Wake Forest University Baptist Medical Center graduates its first class from the ED Academy, a six-month training program for new nursing graduates to work in the ED.
A new assessment tool, reported recently by the Journal of Hospital Medicine, may help hospitals avoid under- or over-treating patients who are admitted through hospital emergency departments (EDs).
A fast-acting compound that appears to improve cognitive function impairments in mice similar to those found in patients with progressive Alzheimer’s disease has been identified by scientists at Wake Forest University School of Medicine and the Vanderbilt University Medical Center Program in Drug Discovery. Researchers hope to one day replicate the result in humans.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right